LIA
UTHR icon

LS Investment Advisors’s United Therapeutics UTHR Stock Holding History

LS Investment Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,060
Closed -$345K – 703
2021
Q1 		$345K Sell
2,060
-457
-18% -$76.2K 0.02% 523
2020
Q4 		$382K Hold
2,517
– – 0.02% 522
2020
Q3 		$254K Hold
2,517
– – 0.01% 633
2020
Q2 		$305K Buy
2,517
+138
+6% +$15.5K 0.02% 555
2020
Q1 		$226K Hold
2,379
– – 0.02% 586
2019
Q4 		$210K Hold
2,379
– – 0.01% 780
2019
Q3 		$190K Buy
2,379
+74
+3% +$5.96K 0.01% 795
2019
Q2 		$180K Sell
2,305
-1,067
-32% -$99.8K 0.01% 828
2019
Q1 		$396K Sell
3,372
-94
-3% -$11K 0.02% 535
2018
Q4 		$377K Buy
3,466
+25
+0.7% +$2.9K 0.03% 517
2018
Q3 		$440K Sell
3,441
-10
-0.3% -$1.24K 0.03% 552
2018
Q2 		$390K Buy
3,451
+80
+2% +$8.79K 0.02% 600
2018
Q1 		$379K Sell
3,371
-254
-7% -$32.3K 0.02% 600
2017
Q4 		$536K Sell
3,625
-763
-17% -$97K 0.03% 468
2017
Q3 		$514K Sell
4,388
-239
-5% -$30.5K 0.03% 502
2017
Q2 		$600K Buy
4,627
+632
+16% +$78.8K 0.04% 419
2017
Q1 		$541K Buy
3,995
+100
+3% +$15.1K 0.03% 423
2016
Q4 		$559K Buy
3,895
+11
+0.3% +$1.4K 0.04% 376
2016
Q3 		$459K Sell
3,884
-209
-5% -$25.1K 0.03% 417
2016
Q2 		$434K Buy
4,093
+1,386
+51% +$155K 0.03% 466
2016
Q1 		$302K Buy
2,707
+126
+5% +$15.9K 0.02% 552
2015
Q4 		$404K Buy
2,581
+102
+4% +$14.8K 0.03% 460
2015
Q3 		$325K Sell
2,479
-74
-3% -$11.9K 0.03% 525
2015
Q2 		$444K Buy
+2,553
New +$459K 0.03% 422

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

LS Investment Advisors's UTHR Position: Q2 2021 in Review

LS Investment Advisors sold out of United Therapeutics (UTHR) in Q2 2021, closing a stake of 2,060 shares — an estimated $345K sold.

LS Investment Advisors first reported a position in UTHR in Q2 2015 and held it in 24 quarters. The position peaked at $600K in Q2 2017. 403 funds tracked by Wall St. Rank hold UTHR as of Q2 2021.

  • LS Investment Advisors reported no remaining United Therapeutics position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 2,060 United Therapeutics shares in Q2 2021, an estimated $345K.
  • LS Investment Advisors first reported a position in United Therapeutics in Q2 2015 and held it in 24 quarters.
  • LS Investment Advisors's United Therapeutics position peaked at $600K in Q2 2017.
  • 403 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.